Landiolol for managing post-operative atrial fibrillation
- PMID: 30188958
- PMCID: PMC5909769
- DOI: 10.1093/eurheartj/sux036
Landiolol for managing post-operative atrial fibrillation
Abstract
Beta-blockers are a potential option to manage peri-operative atrial fibrillation. Landiolol is a new ultra-short beta-blocker with a half-life of only 4 minutes and very high beta-1 selectivity which has been used for treatment and prevention of atrial fibrillation in pulmonary surgery and gastro-intestinal surgery. Due to its limited negative inotropic effect and high beta-1 selectivity landiolol allows for control of heart rate with minimal impact on blood pressure. Landiolol is well tolerated by the respiratory system. Additional benefits are related to the regulation of the inflammatory response and blunting of the adrenergic pathway. There is a limited number of trials with total of 61 patients undergoing lung resection or oesophagectomy who developed post-operative atrial fibrillation and were treated with landiolol. The experience with landiolol for prevention is more documented than landiolol application for treatment of post-operative atrial fibrillation. There are 9 comparative studies with a total of 450 patients administered landiolol for prevention of post-operative atrial fibrillation. The use of low dosage (5-10mcg/kg/min) is usually sufficient to rapidly control heart rate which is associated with earlier and higher rate of conversion to sinus rhythm as compared to the controls. The excellent tolerance of landiolol at lower dosage (3-5mcg/kg/min) allows to initiate prophylactic use during surgery and postoperatively. Landiolol prophylaxis is associated with reduced incidence of post-operative atrial fibrillation without triggering adverse events related to a beta-blockade.
Keywords: Antiarrhythmic therapy; Atrial fibrillation; Cardioversion; Diastolic dysfunction; Landiolol; Supraventricular arrhythmia.
Figures
Similar articles
-
Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.J Clin Pharm Ther. 2012 Aug;37(4):431-5. doi: 10.1111/j.1365-2710.2011.01315.x. Epub 2011 Nov 7. J Clin Pharm Ther. 2012. PMID: 22059486
-
Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: Prevention of Atrial Fibrillation After Cardiac Surgery With Landiolol Hydrochloride for Left Ventricular Dysfunction (PLATON) trial.J Thorac Cardiovasc Surg. 2015 Oct;150(4):957-64. doi: 10.1016/j.jtcvs.2015.07.003. Epub 2015 Jul 10. J Thorac Cardiovasc Surg. 2015. PMID: 26254752 Clinical Trial.
-
Efficacy of low-dose landiolol, an ultrashort-acting β-blocker, on postoperative atrial fibrillation in patients undergoing pulmonary resection for lung cancer.Gen Thorac Cardiovasc Surg. 2011 Dec;59(12):799-805. doi: 10.1007/s11748-011-0841-x. Epub 2011 Dec 16. Gen Thorac Cardiovasc Surg. 2011. PMID: 22173677
-
Landiolol for Treatment of New-Onset Atrial Fibrillation in Critical Care: A Systematic Review.J Clin Med. 2024 May 17;13(10):2951. doi: 10.3390/jcm13102951. J Clin Med. 2024. PMID: 38792492 Free PMC article. Review.
-
Novel rate control strategy with landiolol in patients with cardiac dysfunction and atrial fibrillation.ESC Heart Fail. 2020 Oct;7(5):2208-2213. doi: 10.1002/ehf2.12879. Epub 2020 Jul 14. ESC Heart Fail. 2020. PMID: 32666693 Free PMC article. Review.
Cited by
-
Urgent Control of Rapid Atrial Fibrillation by Landiolol in Patients With Acute Decompensated Heart Failure With Severely Reduced Ejection Fraction.Circ Rep. 2019 Sep 26;1(10):422-430. doi: 10.1253/circrep.CR-19-0076. Circ Rep. 2019. PMID: 33693079 Free PMC article.
-
Landiolol hydrochloride for prevention of atrial fibrillation during esophagectomy: a randomized controlled trial.JA Clin Rep. 2020 May 11;6(1):34. doi: 10.1186/s40981-020-00338-3. JA Clin Rep. 2020. PMID: 32394218 Free PMC article.
-
Intravenous Landiolol for Rate Control in Supraventricular Tachyarrhythmias in Patients with Left Ventricular Dysfunction: A Systematic Review and Meta-Analysis.J Clin Med. 2024 Mar 14;13(6):1683. doi: 10.3390/jcm13061683. J Clin Med. 2024. PMID: 38541908 Free PMC article. Review.
-
Intravenous landiolol for the prevention of atrial fibrillation after aortic root, ascending aorta, and aortic arch surgery: A propensity score-matched analysis.JTCVS Open. 2022 Jun 22;11:49-58. doi: 10.1016/j.xjon.2022.06.010. eCollection 2022 Sep. JTCVS Open. 2022. PMID: 36172424 Free PMC article.
-
Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature.Vasc Health Risk Manag. 2020 Apr 3;16:111-123. doi: 10.2147/VHRM.S210561. eCollection 2020. Vasc Health Risk Manag. 2020. PMID: 32308404 Free PMC article. Review.
References
-
- Raman T, Roistacher N, Liu J, Zhang H, Shi W, Thaler HT, Amar D.. Preoperative left atrial dysfunction and risk of postoperative atrial fibrillation complicating thoracic surgery. J Thorac Cardiovasc Surg 2012;143:482–487. - PubMed
-
- Amar D, Zhang H, Shi W, Downey RJ, Bains MS, Park BJ, Flores R, Rizk N, Thaler HT, Rusch VW.. Brain natriuretic peptide and risk of atrial fibrillation after thoracic surgery. J Thorac Cardiovasc Surg 2012;144:1249–1253. - PubMed
-
- Ojima T, Iwahashi M, Nakamori M, Nakamura M, Katsuda M, Iida T, Hayata K, Yamaue H.. Atrial fibrillation after esophageal cancer surgery: an analysis of 207 consecutive patients. Surg Today 2014;44:839–847. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources